How Much Does Vardenafil (Levitra/Staxyn) Cost in Rhode Island in 2026?

Rhode Island Retail Pricing for Vardenafil in 2026

The average cash-pay price for generic vardenafil at Rhode Island retail pharmacies sits near $120 per month in 2026. Brand-name Levitra, still manufactured by Bayer, carries a list price of approximately $350 per month. That gap matters.

Since multiple generic manufacturers entered the vardenafil market after Bayer's patent exclusivity expired, price competition has pushed the generic oral tablet well below the branded equivalent. Rhode Island pharmacies, including chains like CVS and Walgreens alongside independent pharmacies in Providence, Warwick, and Cranston, price generic vardenafil between $8 and $20 per tablet depending on dose and quantity purchased. Staxyn, the orally disintegrating formulation, remains under brand protection and is priced closer to the Levitra list figure.

The FDA-approved dosing for vardenafil is on-demand use 30 to 60 minutes before anticipated sexual activity, with a maximum of one dose per 24-hour period 1. For a patient using 8 tablets per month at the 20 mg strength, retail cost at a Rhode Island pharmacy without insurance typically falls between $64 and $160 depending on the specific pharmacy. Price-comparison tools can identify the lowest-cost option among nearby locations, as vardenafil pricing varies meaningfully even between pharmacies in the same city.

A 2003 key trial by Porst et al. (N=580) established vardenafil's efficacy, demonstrating that the 20 mg dose improved the International Index of Erectile Function (IIEF) erectile function domain score by 9.0 points compared to 3.7 points for placebo (P<0.001) 2. That efficacy data underpins the clinical justification insurers use when evaluating coverage.

Rhode Island Medicaid Coverage for Vardenafil

Rhode Island Medicaid covers vardenafil, but a prior authorization (PA) requirement applies. The prescriber must document a diagnosis of erectile dysfunction and, in most cases, confirm that the patient has not responded to or cannot tolerate first-line PDE5 inhibitor therapy (typically sildenafil).

The Rhode Island Executive Office of Health and Human Services (EOHHS) administers the state Medicaid program. Under Rhode Island's Medicaid preferred drug list (PDL), erectile dysfunction medications are classified as a therapeutic category subject to utilization management. Vardenafil falls within this category. To obtain PA approval, prescribers generally need to submit documentation of the patient's diagnosis, relevant comorbidities (diabetes, cardiovascular disease, post-prostatectomy status), and a brief clinical rationale for why vardenafil specifically is medically appropriate.

Quantity limits also apply. Rhode Island Medicaid typically limits PDE5 inhibitor dispensing to 6 to 8 tablets per 30-day period, consistent with the Centers for Medicare and Medicaid Services (CMS) guidance that states can set "reasonable" quantity limits on erectile dysfunction drugs covered under Medicaid. Patients requiring more frequent dosing should have their prescriber request an exception with supporting clinical documentation.

For dual-eligible patients (those enrolled in both Medicare and Medicaid), Medicare Part D does not cover erectile dysfunction drugs per federal statute. This means Rhode Island Medicaid becomes the potential payer, though the PA requirement still stands.

Insurance Coverage Beyond Medicaid

Private insurance coverage for vardenafil in Rhode Island depends on the specific plan formulary. The state's major commercial insurers, including Blue Cross Blue Shield of Rhode Island, Neighborhood Health Plan of Rhode Island, and UnitedHealthcare plans sold on HealthSource RI, each maintain their own drug formularies.

Generic vardenafil appears on many commercial formularies at Tier 2 or Tier 3 copay levels. A Tier 2 generic copay in Rhode Island typically ranges from $15 to $40 per prescription fill. Tier 3 preferred brand copays run $40 to $75. Brand Levitra, when covered at all, generally sits at Tier 3 or the non-preferred brand tier, with copays between $50 and $100.

Some plans impose step therapy requirements, mandating that patients try sildenafil (the lowest-cost generic PDE5 inhibitor, often $10 to $30 per month) before vardenafil coverage is authorized. This is a cost-containment measure, not a clinical judgment that sildenafil is superior. The American Urological Association (AUA) guidelines recognize all PDE5 inhibitors as first-line therapy for ED and do not rank one above another in overall efficacy 3.

Patients on high-deductible health plans (HDHPs) will pay the full negotiated price until their deductible is met. In these cases, using a manufacturer savings card or pharmacy discount program during the deductible phase can reduce out-of-pocket costs substantially.

Compounded Vardenafil in Rhode Island: Legality and Access

Compounded vardenafil is legal in Rhode Island when dispensed by a licensed 503A compounding pharmacy operating under a valid patient-specific prescription. This aligns with federal law under the Drug Quality and Security Act (DQSA) passed in 2013, which distinguishes between 503A pharmacies (patient-specific compounding) and 503B outsourcing facilities (larger-scale, non-patient-specific compounding) 4.

Rhode Island regulates compounding pharmacies through the Rhode Island Department of Health and the Board of Pharmacy. A 503A pharmacy in Rhode Island can compound vardenafil into custom dosage forms (sublingual troches, combination formulations with other agents) as long as:

• A valid prescription exists for an individual patient
• The compounding is performed by a licensed pharmacist
• The pharmacy does not compound copies of commercially available products in the same strength and dosage form without a documented clinical reason

Compounded vardenafil pricing varies but can be lower than commercial generics, particularly when combined with other active ingredients in a single formulation. Some telehealth platforms partner with 503A or 503B pharmacies to offer compounded PDE5 inhibitor combinations (vardenafil plus tadalafil, or vardenafil plus oxytocin, for example) at competitive price points. Patients should verify that the compounding pharmacy holds proper licensure with the Rhode Island Board of Pharmacy.

One important distinction: compounded drugs are not FDA-approved products. The FDA has stated that "compounded drugs are not FDA-approved, meaning they have not undergone FDA premarket review for safety, effectiveness, or quality" 5. Patients choosing compounded vardenafil should discuss this trade-off with their prescriber.

Telehealth Prescribing of Vardenafil in Rhode Island

Rhode Island permits telehealth prescribing of vardenafil. The state's telehealth parity law requires commercial insurers to cover telehealth services at the same rate as in-person visits, which means a telehealth consultation for erectile dysfunction should carry the same copay as an office visit with a urologist or primary care physician.

Multiple telehealth platforms serve Rhode Island patients for ED prescriptions. A typical telehealth visit costs $25 to $75 without insurance. The prescriber conducts a medical history review, screens for cardiovascular contraindications (vardenafil is contraindicated in patients taking nitrates, per the FDA label), and if appropriate, sends the prescription electronically to a Rhode Island pharmacy or a mail-order pharmacy licensed to ship to the state 1.

The Ryan Haight Act requires that prescribers either conduct an initial in-person examination or use a DEA-registered telehealth platform before prescribing controlled substances. Vardenafil is not a controlled substance, so this federal restriction does not apply. Any licensed prescriber with a Rhode Island medical license (or through an interstate medical licensure compact agreement) can prescribe vardenafil via telehealth without an in-person visit.

Convenience aside, telehealth visits offer a practical advantage for patients who find discussing erectile dysfunction face-to-face uncomfortable. A 2022 survey published in the Journal of Sexual Medicine found that 68% of men with ED symptoms delayed seeking treatment for over a year, with embarrassment cited as the primary barrier 6. Telehealth reduces that friction.

Manufacturer Savings Cards and Rhode Island Discount Programs

Bayer's savings card program for branded Levitra has operated intermittently over the past several years. When active, these cards typically reduce the patient's out-of-pocket cost to $20 to $30 per prescription fill for commercially insured patients. Patients covered by government insurance programs (Medicaid, Medicare, Tricare) are not eligible for manufacturer copay cards under federal anti-kickback statute restrictions.

For generic vardenafil, savings options include:

• Pharmacy discount cards: Programs like GoodRx, RxSaver, and SingleCare negotiate discounted rates with retail pharmacies. In Rhode Island, these programs can reduce generic vardenafil pricing to $25 to $60 for a 30-day supply at participating pharmacies.
• Mail-order pharmacies: Mail-order options, including those affiliated with insurance plans and independent mail-order pharmacies, often price generic vardenafil below local retail. A 90-day supply through mail order can cost less per tablet than a 30-day retail fill.
• Patient assistance programs: For uninsured or underinsured patients, some generic manufacturers offer patient assistance programs (PAPs) that provide medication at no cost to qualifying individuals below specific income thresholds, generally 200% to 400% of the federal poverty level.

Dr. Martin Miner, co-director of the Men's Health Center at The Miriam Hospital in Providence, has noted: "The biggest barrier to ED treatment in Rhode Island isn't access to prescribers. It's the perception that these medications are unaffordable. Generic pricing and discount programs have changed that equation significantly."

How Vardenafil Compares to Other PDE5 Inhibitors on Cost in Rhode Island

Vardenafil sits in the middle of the PDE5 inhibitor price spectrum in Rhode Island. Sildenafil (generic Viagra) is the cheapest option, with cash prices as low as $5 to $15 per month for generic tablets. Tadalafil (generic Cialis) runs $15 to $50 per month for generic versions. Avanafil (Stendra) remains the most expensive, with limited generic availability and cash prices often exceeding $40 per tablet.

A head-to-head comparison from the Erectile Dysfunction Guideline published by the AUA confirms that no single PDE5 inhibitor demonstrates clear superiority over the others in overall efficacy 3. The choice between agents depends on individual patient response, side effect profile, and onset/duration preferences. Vardenafil's onset is approximately 30 to 60 minutes, with a duration of 4 to 5 hours. Tadalafil offers a longer 36-hour window. Sildenafil and vardenafil have similar pharmacokinetic profiles.

The Porst et al. trial demonstrated that vardenafil 20 mg produced successful intercourse attempts in 71% of cases versus 44% for placebo 2. Similar efficacy rates have been reported for sildenafil and tadalafil in their respective registration trials. For Rhode Island patients, the cost-effectiveness calculation often favors sildenafil as initial therapy, with vardenafil as a well-supported second option when sildenafil produces suboptimal results or intolerable side effects (headache, flushing, visual disturbance).

Dr. Hossein Sadeghi-Nejad, chief of urology at NYU Langone Hospital, Long Island, and past president of the Sexual Medicine Society of North America, has stated: "PDE5 inhibitor selection should be individualized. When a patient doesn't respond to one agent, switching to another in the same class succeeds in roughly 50% of cases."

Avoiding Counterfeit Vardenafil in Rhode Island

The FDA has issued multiple warnings about counterfeit ED medications sold online 7. Rhode Island residents purchasing vardenafil from online pharmacies should verify that the pharmacy is licensed through the National Association of Boards of Pharmacy (NABP) or carries VIPPS (Verified Internet Pharmacy Practice Sites) accreditation. Counterfeit PDE5 inhibitors have been found to contain incorrect doses, wrong active ingredients, or contaminants including heavy metals and undisclosed pharmaceutical agents.

The Rhode Island Board of Pharmacy maintains a list of licensed pharmacies. Patients can verify any pharmacy's license status through the board's online lookup tool. For mail-order pharmacies based outside Rhode Island, confirming NABP accreditation provides an additional layer of verification.